{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,12]],"date-time":"2023-10-12T05:25:44Z","timestamp":1697088344201},"reference-count":42,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2005,5,12]],"date-time":"2005-05-12T00:00:00Z","timestamp":1115856000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Deutsche Derma Gesell"],"published-print":{"date-parts":[[2005,6]]},"abstract":"<jats:title>Zusammenfassung<\/jats:title><jats:p>Das einer steigenden Inzidenz unterliegende maligne Melanom entsteht als melanozyt\u00e4re Geschwulst \u00fcberwiegend auf der Haut und ist f\u00fcr etwa 90\u2003% der Mortalit\u00e4t an b\u00f6sartigen Hauttumoren verantwortlich. Als wichtigster Risikofaktor wurde noch vor dem UV\u2010Licht die genetische Disposition erkannt, wobei sich das Risiko durch bedachte UV\u2010Licht\u2010Exposition reduzieren l\u00e4\u00dft. Wichtige neue diagnostische Verfahren sind die Sentinel\u2010Lymphadenektomie und der Einsatz von Tumormarkern im Blut. Das Melanom zeichnet sich durch eine ausgepr\u00e4gte Therapieresistenz aus, so da\u00df die derzeit einzige kurative Therapie in der fr\u00fchen Exzision zu sehen ist. Damit ist eine verbesserte Fr\u00fcherkennung essentiell. Experimentelle Therapieans\u00e4tze wie die Vakzinierung mit dendritischen Zellen zeigen erste Erfolge, m\u00fcssen aber in multizentrischen, randomisierten Studien noch \u00fcberpr\u00fcft werden.<\/jats:p>","DOI":"10.1111\/j.1610-0387.2005.05024.x","type":"journal-article","created":{"date-parts":[[2005,5,12]],"date-time":"2005-05-12T09:27:57Z","timestamp":1115890077000},"page":"421-430","source":"Crossref","is-referenced-by-count":0,"title":["Malignes Melanom \u2013 Eine Betrachtung von Studenten der Humanmedizin"],"prefix":"10.1111","volume":"3","author":[{"given":"Moritz","family":"Felcht","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jens Christian","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Michels","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Weinhold","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christos C.","family":"Zouboulis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2005,5,12]]},"reference":[{"key":"e_1_2_15_2_2","unstructured":"OrfanosCE GarbeC. Therapie der Hautkrankheiten Springer Verlag Berlin Heidelberg New York 2002 895\u200a\u2013\u200a967."},{"key":"e_1_2_15_3_2","unstructured":"VolkenandtM PlewigG. Maligne Melanome \u2013 Empfehlungen zur Diagnostik Therapie und Nachsorge Tumorzentrum M\u00fcnchen. Zuckschwerdt Verlag M\u00fcnchen 2000."},{"key":"e_1_2_15_4_2","unstructured":"Strahlenschutzkommission. Ultraviolette Strahlung und Malignes Melanom. Bewertung epidemiologischer Studien 1990\u200a\u2013\u200a1996. Stellungnahme der Strahlenschutzkommission vom 24. September 1998. In: Ver\u00f6ffentlichungen der Strahlenschutzkommission Band 44 Gustav Fischer Verlag Stuttgart."},{"key":"e_1_2_15_5_2","unstructured":"DeutingerM PehambergerH KerlH KokoschkaEM KollerR WaclawiczekHW MeisslG ZanonE SmolaMG ScharnaglSeewald D. Malignes Melanom der Haut. In: ACO\u2010Manual. http:\/\/www.aco.at\/manual."},{"key":"e_1_2_15_6_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-4362.2001.01132.x"},{"key":"e_1_2_15_7_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199904293401707"},{"key":"e_1_2_15_8_2","doi-asserted-by":"crossref","unstructured":"SharplessNE ChinL. The INK4a\/ARF locus and melanoma. Oncogene 2003; 22 3092\u200a\u2013\u200a3098.","DOI":"10.1038\/sj.onc.1206461"},{"key":"e_1_2_15_9_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-4362.2002.01601.x"},{"key":"e_1_2_15_10_2","doi-asserted-by":"publisher","DOI":"10.1101\/gad.12.19.2984"},{"key":"e_1_2_15_11_2","doi-asserted-by":"publisher","DOI":"10.1101\/gad.12.22.3467"},{"key":"e_1_2_15_12_2","first-page":"74","article-title":"Sonnenbrand und Hautkrebs","volume":"6","author":"Leffell DJ","year":"1997","journal-title":"Spektrum Wiss"},{"key":"e_1_2_15_13_2","unstructured":"AzemarM HildenbrandB. Metastasen \u2013 Von der Biologie zur Therapie. Klinikarzt 2001; 322\u200a\u2013\u200a327."},{"key":"e_1_2_15_14_2","unstructured":"SchadendorfD. Vakzination beim Melanom \u2013 Eine \u00dcbersicht des derzeitigen Entwicklungsstands. Med Review 2001; 9."},{"key":"e_1_2_15_15_2","doi-asserted-by":"publisher","DOI":"10.1007\/s001050051289"},{"key":"e_1_2_15_16_2","doi-asserted-by":"publisher","DOI":"10.1007\/s001050050503"},{"key":"e_1_2_15_17_2","first-page":"13S","article-title":"Current practice and future directions in pathology and laboratory evaluation of the sentinel node","volume":"8","author":"Cochran AJ","year":"2001","journal-title":"Ann Surg Oncol"},{"key":"e_1_2_15_18_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2559.2002.01512.x"},{"key":"e_1_2_15_19_2","doi-asserted-by":"publisher","DOI":"10.1097\/00008390-200208000-00002"},{"key":"e_1_2_15_20_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1747.1998.00131.x"},{"key":"e_1_2_15_21_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2001.04334.x"},{"key":"e_1_2_15_22_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1440-1827.2002.01344.x"},{"key":"e_1_2_15_23_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2001.04015.x"},{"key":"e_1_2_15_24_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2001.04332.x"},{"key":"e_1_2_15_25_2","unstructured":"Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften. Interdisziplin\u00e4re kurzgefa\u00dfte Leitlinien der Deutschen Krebsgesellschaft und der Deutschen Dermatologischen Gesellschaft. 2001; http: \/\/www.uni\u2010duesseldorf.de\/WWW\/AWMF\/ll\/derm\u2010o05.htm."},{"key":"e_1_2_15_26_2","first-page":"46","article-title":"Aktuelle Therapiestrategien beim malignen Melanom","volume":"2","author":"Kohlmus C","year":"1996","journal-title":"Arzneimitteltherapie"},{"key":"e_1_2_15_27_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra041245"},{"key":"e_1_2_15_28_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2230.2000.00690.x"},{"key":"e_1_2_15_29_2","unstructured":"SchlemmerM LindnerLH Abdel\u2010RahmanS IsselsRD. Prinzip Technik und Indikation der Hyperthermie und Teilk\u00f6rperhyperthermie. Der Radiologe 2004; Springer\u2010Verlag 10.10;007."},{"key":"e_1_2_15_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2004.05.001"},{"key":"e_1_2_15_31_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2230.2002.01152.x"},{"key":"e_1_2_15_32_2","doi-asserted-by":"publisher","DOI":"10.1038\/89863"},{"key":"e_1_2_15_33_2","doi-asserted-by":"publisher","DOI":"10.1038\/30996"},{"key":"e_1_2_15_34_2","doi-asserted-by":"publisher","DOI":"10.1038\/30989"},{"key":"e_1_2_15_35_2","unstructured":"TerheydenP Br\u00f6ckerE\u2010B K\u00e4mpgenE BeckerJ FischerW. Tumorimmunit\u00e4t am Beispiel des malignen Melanoms. Blick1999; (1): Artikel 5 http:\/\/www.uni\u2010wuerzburg.de\/blick\/1999\u20101\/991d05\u2010t.html."},{"key":"e_1_2_15_36_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.164.12.6633"},{"key":"e_1_2_15_37_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm0398-328"},{"key":"e_1_2_15_38_2","doi-asserted-by":"publisher","DOI":"10.1159\/000055242"},{"key":"e_1_2_15_39_2","first-page":"1837","article-title":"The unfulfilled promise of melanoma vaccines","volume":"7","author":"Livingston P","year":"2001","journal-title":"Clin Cancer Res"},{"key":"e_1_2_15_40_2","doi-asserted-by":"publisher","DOI":"10.1159\/000055004"},{"key":"e_1_2_15_41_2","first-page":"2277","article-title":"Prevention and early detection of malignant melanoma","volume":"62","author":"Edman RL","year":"2000","journal-title":"Am Fam Physician"},{"key":"e_1_2_15_42_2","doi-asserted-by":"crossref","unstructured":"GriffioenM BorghiM SchrierPI OsantoS SchadendorfD. Analysis of T\u2010cell responses in metastatic melanoma patients vaccinated with dendritic cells pulsed with tumor lysates. Cancer Immunol Immunother 2004; Mar 3 [Epub ahead of print].","DOI":"10.1007\/s00262-004-0514-z"},{"key":"e_1_2_15_43_2","doi-asserted-by":"crossref","first-page":"5071","DOI":"10.4049\/jimmunol.154.10.5071","article-title":"Dendritic cells produce IL\u201012 and direct the development of Th1 cells from naive CD4+ T cells","volume":"154","author":"Macatonia SE","year":"1995","journal-title":"J Immunol"}],"container-title":["JDDG: Journal der Deutschen Dermatologischen Gesellschaft"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1610-0387.2005.05024.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1610-0387.2005.05024.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,12]],"date-time":"2023-10-12T01:30:34Z","timestamp":1697074234000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1610-0387.2005.05024.x"}},"subtitle":["Malignant melanoma \u2013 A medical students' viewpoint"],"short-title":[],"issued":{"date-parts":[[2005,5,12]]},"references-count":42,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2005,6]]}},"alternative-id":["10.1111\/j.1610-0387.2005.05024.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1610-0387.2005.05024.x","archive":["Portico"],"relation":{},"ISSN":["1610-0379","1610-0387"],"issn-type":[{"value":"1610-0379","type":"print"},{"value":"1610-0387","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,5,12]]}}}